These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 18348656

  • 1. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 2. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E, Tripsianis G, Anagnostopoulos K, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [Abstract] [Full Text] [Related]

  • 3. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E, Simopoulos K, Tripsianis G, Tentes I, Anagnostopoulos K, Sivridis E, Galazios G, Kortsaris A.
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [Abstract] [Full Text] [Related]

  • 4. Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
    Souder C, Leitzel K, Ali SM, Demers L, Evans DB, Chaudri-Ross HA, Hackl W, Hamer P, Carney W, Lipton A.
    Cancer; 2006 Nov 15; 107(10):2337-45. PubMed ID: 17048231
    [Abstract] [Full Text] [Related]

  • 5. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.
    Ann N Y Acad Sci; 2008 Sep 15; 1138():84-94. PubMed ID: 18837888
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD.
    J Surg Res; 2007 Jul 15; 141(1):53-9. PubMed ID: 17574038
    [Abstract] [Full Text] [Related]

  • 11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R, Yip CH, Taib NA.
    Neoplasma; 2008 Aug 10; 55(2):87-95. PubMed ID: 18237245
    [Abstract] [Full Text] [Related]

  • 13. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Aug 10; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 14. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Aug 10; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 15. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P, Kajo K, Stanclova A, Szunyogh N, Galo S, Dussan CA, Minarik G, Visnovsky J, Danko J.
    Eur J Cancer Prev; 2008 Feb 10; 17(1):33-8. PubMed ID: 18090908
    [Abstract] [Full Text] [Related]

  • 16. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H.
    Breast Cancer Res Treat; 2009 Sep 10; 117(1):131-40. PubMed ID: 18932017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.
    Clin Cancer Res; 2005 Jul 01; 11(13):4775-8. PubMed ID: 16000574
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.